Services

Listings

• 

  L929/A

  Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

  This Adriamycin-resistant cell line has been developed by exposure of the parent L929 murine fibroblast cell line to increasing concentrations of doxorubicin in-vitro. L929/A cells can be used in the development of novel anti-cancer treatments. Resis...

• 

  NMuMG

  Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

  Initiated from the mammary gland tissue of an adult NAMRU mouse and one of a series of epithelial cell lines derived from normal glandular tissue of mice. The cells exhibit many ultrastructural features of secretory epithelium as well as desmosomes o...

• 

  Hepa 1-clc7

  Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

  Species: mouse, C57L; Tissue: liver; Tumor: hepatoma, BW7756; Derived from: Hepa-1cl, cloned from the Hepa-1 cell line https://www.creative-bioarray.com/Hepa-1-clc7-CSC-6264W-item-1508.htm

• 

  MPP 89

  Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

  Cat.No. CSC-6299W Description Species: human male 67 years old; Tissue: pleural effusion; Tumor: mesothelioma Species Homo sapiens (Human) Source Pleural Effusion https://www.creative-bioarray.com/MPP-89-CSC-6299W-item-1022.htm

• 

  MP38

  Immunology Shirley (New York) September 30, 2026 1.00 Dollar US$

  Cat.No. CSC-C7067J Description established from the uvea tissue of a male patient with uveal melanoma Species Homo sapiens (Human) Source Eye; Uvea Recommended Medium RPMI-1640 + 20% FBS https://www.creative-bioarray.com/mp38-csc-c7067j-item-49110.ht...

• 

  MFE-280

  Immunology Shirley (New York) September 29, 2026 1.00 Dollar US$

  Established from tumor tissue from a 77-year-old woman with recurrence of endometrial carcinoma (adenomatous, partly papillary, grade G3) in 1990; described as forming heterotransplantable tumors in nude mice and as carrying receptors for progesteron...

• 

  COLO-679

  Immunology Shirley (New York) September 29, 2026 1.00 Dollar US$

  Cat.No. CSC-C0363 Description Established in 1985 from the soft tissue metastasis of a malignant melanoma from a 47-year-old woman Species Homo sapiens (Human) Source Soft Tissue Metastasis https://www.creative-bioarray.com/COLO-679-CSC-C0363-item-11...

• 

  COLO 741

  Immunology Shirley (New York) September 29, 2026 1.00 Dollar US$

  Species: human female 69 years; Tissue: colon; Tumor: carcinoma; Derived from: pelvic wall metastasis https://www.creative-bioarray.com/COLO-741-CSC-C2204-item-1440.htm

• 

  Bovine Skeletal Muscle Cells

  Immunology Shirley (New York) September 17, 2026 1.00 Dollar US$

  Bovine Skeletal Muscle Muscle cells from Creative Bioarray are isolated from bovine tissue. Prior to shipping, cells at passage 2 are detached from flasks and immediately cryopreserved in vials. Each vial contains at least 0.5×10^6 cells per ml. The ...

• 

  Omental Preadipocytes

  Immunology Shirley (New York) September 17, 2026 1.00 Dollar US$

  Preadipocytes are isolated from omental, mesenteric, or perirenal adipose tissue and are tested for their ability to differentiate in culture to mature adipocytes. Preadipocytes are available cryopreserved or plated and mature adipocytes are availabl...

• 

  Leiomyosarcoma Tissue MicroArray

  Immunology Shirley (New York) June 23, 2026 1.00 Dollar US$

  Leiomyosarcoma tissue microarray, single core per case, 24 cases of leiomyosarcoma in mild malignancy, moderate malignancy or severe malignancy Applications IHC, IHC-P, ISH Tissue Type Multi-tissue Storage Store at 4℃. Tissue Array Type FFPE Species ...

• 

  Custom CRISPR iPSC Services: Revolutionizing Cellular Research

  Molecular Biology Shirley (New York) November 4, 2025 1.00 Dollar US$

  In recent years, the emergence of CRISPR technology has transformed the landscape of genetic research and therapy. Among its most significant applications is the use of induced pluripotent stem cells (iPSCs), which are derived from adult somatic cell...